Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Merrill

Showing results (191-200 of 414) with videos related to

Pageof 42
Sort By:
Lupus Science & Medicine|January 11, 2020
Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measuresAikaterini Thanou, Judith A James, Cristina Arriens, et al.
The Journal of Rheumatology|April 3, 2013
Efficacy and safety of belimumab in patients with rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled, dose-ranging StudyWilliam Stohl, Joan T Merrill, James D McKay, et al.
Thrombosis and Haemostasis|June 12, 1999
Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding proteinJ T Merrill, H W Zhang, C Shen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 22, 2026
"More Guidelines Than Rules": Reconsidering Key Gaps in the 2025 American College of Rheumatology Treatment Recommendations for Systemic Lupus ErythematosusSaira Sheikh, Karen H Costenbader, Joan T Merrill, et al.
The New Phytologist|August 27, 2022
Comparative transcriptomics and metabolomics reveal specialized metabolite drought stress responses in switchgrass (Panicum virgatum)Kira Tiedge, Xingxing Li, Amy T Merrill, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplificationC T Fong, N C Dracopoli, P S White, et al.
Lupus Science & Medicine|March 24, 2020
Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriersCristina Arriens, Teresa Aberle, Fredonna Carthen, et al.
Lupus Science & Medicine|July 14, 2015
A highlight from the LUPUS 2014 meeting: eight great ideasJill P Buyon, Phillip Cohen, Joan T Merrill, et al.
Annals of the Rheumatic Diseases|March 25, 2016
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled studyMunther Khamashta, Joan T Merrill, Victoria P Werth, et al.
Arthritis and Rheumatism|July 1, 1997
Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritisJ T Merrill, C Shen, D Schreibman, et al.
Pageof 42

Showing results (191-200 of 414) with videos related to

Sort By:
Pageof 42
Lupus Science & Medicine|January 11, 2020
Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measuresAikaterini Thanou, Judith A James, Cristina Arriens, et al.
The Journal of Rheumatology|April 3, 2013
Efficacy and safety of belimumab in patients with rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled, dose-ranging StudyWilliam Stohl, Joan T Merrill, James D McKay, et al.
Thrombosis and Haemostasis|June 12, 1999
Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding proteinJ T Merrill, H W Zhang, C Shen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 22, 2026
"More Guidelines Than Rules": Reconsidering Key Gaps in the 2025 American College of Rheumatology Treatment Recommendations for Systemic Lupus ErythematosusSaira Sheikh, Karen H Costenbader, Joan T Merrill, et al.
The New Phytologist|August 27, 2022
Comparative transcriptomics and metabolomics reveal specialized metabolite drought stress responses in switchgrass (Panicum virgatum)Kira Tiedge, Xingxing Li, Amy T Merrill, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplificationC T Fong, N C Dracopoli, P S White, et al.
Lupus Science & Medicine|March 24, 2020
Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriersCristina Arriens, Teresa Aberle, Fredonna Carthen, et al.
Lupus Science & Medicine|July 14, 2015
A highlight from the LUPUS 2014 meeting: eight great ideasJill P Buyon, Phillip Cohen, Joan T Merrill, et al.
Annals of the Rheumatic Diseases|March 25, 2016
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled studyMunther Khamashta, Joan T Merrill, Victoria P Werth, et al.
Arthritis and Rheumatism|July 1, 1997
Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritisJ T Merrill, C Shen, D Schreibman, et al.
Pageof 42